<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMN</journal-id><journal-title-group><journal-title>Open Journal of Modern Neurosurgery</journal-title></journal-title-group><issn pub-type="epub">2163-0569</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmn.2024.141003</article-id><article-id pub-id-type="publisher-id">OJMN-130321</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Evaluation of the Neurodevelopmental Outcome of Toddlers with Spinal Dysraphism after Surgical Repair Using ASQ-3&lt;sup&gt;&amp;#8482;&lt;/sup&gt; Scores
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mujahid</surname><given-names>Imam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fawaz</surname><given-names>Eljili Marhoom</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sawsan</surname><given-names>Aldeaf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ali</surname><given-names>Awad</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmed</surname><given-names>Zidan</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Mustafa Ahmed</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sanna</surname><given-names>Taha</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Neurosurgery Department, Haj Almardi (Al Tamyouz) Hospital, Khartoum, Sudan</addr-line></aff><aff id="aff2"><addr-line>Neurosurgery Department, Royal Care International Hospital, Khartoum, Sudan</addr-line></aff><aff id="aff5"><addr-line>Neurosurgery Department, Al Jazeera Trauma Center, Khartoum, Sudan</addr-line></aff><aff id="aff3"><addr-line>Al Ribat Neurospine Center, Khartoum, Sudan</addr-line></aff><aff id="aff1"><addr-line>Neurosurgery Department, National Center for Neurological Sciences (NCNS), Khartoum, Sudan</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>12</month><year>2023</year></pub-date><volume>14</volume><issue>01</issue><fpage>14</fpage><lpage>29</lpage><history><date date-type="received"><day>9,</day>	<month>October</month>	<year>2023</year></date><date date-type="rev-recd"><day>26,</day>	<month>December</month>	<year>2023</year>	</date><date date-type="accepted"><day>29,</day>	<month>December</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Spinal dysraphism represents a wide spectrum of congenital abnormalities of the spine. Myelomeningocele is considered the most common malformation and the most common we saw in our community, with its morbidity problems seen commonly in the postoperative period. ASQ-3
  <sup>TM</sup> Scores are the ages and stages questionnaire, third edition, and represent a tool to assess the development progress, especially in toddlers. 
  Objectives: Evaluation of neurodevelopmental outcome among Sudanese toddlers with spinal dysraphism after surgical closure with or without a VP shunt using ASQ-3
  <sup>TM</sup> Scores. 
  Methodology: This is a retrospective hospital-based study of 84 patients who underwent myelomeningocele repair at the National Center for Neurological Sciences (NCNS) during the period from 2017 up to 2019. Data were collected through a constructed questionnaire, including ASQ-3
  <sup>TM</sup> Scores. Data were processed and analyzed using the Statistical Package for Social Science (SPSS) computer program. Version 25. 
  Results: 84 patients were included in this study; all patients were diagnosed with spinal dysraphism. Out of them, 51 (60.7%) were 2 years old, 33 (39.3%) were 3 years old, 45 (53.6%) were male, 45 (53.6%) of patients mothers attended ANC irregularly, and 54 (64.3%) their mothers didn’t receive folate supplements. 44 (52.3%) of patients underwent MMC repair only, while 40 (47.7%) underwent MMC repair and VP shunt. The commonest postoperative complication was infection, reported in 12 (14.3%) of patients, followed by VP shunt revision in 9 (10.7%) of patients. Neurological assessment showed that the majority of patients need further assessment with a professional, 57 (67.9%) of children don’t walk, run, or climb like other toddlers as their parent’s state; also, half of patients (42, 50%) had medical problems, and 27 (32.1%) of their parent’s state that they do not talk like other toddlers their age. There was a statistically significant association between post-operative complications and communication development, problem-solving development, and personal social development (P value = 0.05), and a statistically significant association was found between age at repair and neurological development (P value = 0.05). 
  Conclusion: The majority of patients had motor deficiency (particularly gross motor) and poor personal and social skills. Age at repair and postoperative complications significantly influenced the neurological development.
 
</p></abstract><kwd-group><kwd>Toddlers’ Neurodevelopmental Outcome</kwd><kwd> Myelomeningocele Evaluation</kwd><kwd> ASQ-3&lt;sup&gt;&amp;#8482;&lt;/sup&gt; Scores</kwd><kwd> Spinal Dysraphasim</kwd><kwd> Neurodevelopmental Outcome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Background</title><p>Spina bifida literally means “spine in two parts” or “open spine” [<xref ref-type="bibr" rid="scirp.130321-ref1">1</xref>] . Spinal dysraphism involves a spectrum of congenital anomalies resulting in a defective neural arch through which meninges or neural elements are herniated, leading to a variety of clinical manifestations [<xref ref-type="bibr" rid="scirp.130321-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130321-ref2">2</xref>] . They are divided into aperta (a visible lesion) and occulta (with no external lesion) [<xref ref-type="bibr" rid="scirp.130321-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130321-ref2">2</xref>] . Meningocele, myelomeningocele, lipomeningomyelocele, myeloschisis, and rachischisis are the usual names associated with them depending on the pathological findings. Meningocele, by definition, involve only the meninges with no neural involvement; others have a variable extent of neural involvement. The spina bifida aperta is usually associated with a skin defect with an impending risk of CSF leak, constituting “open defects,” whereas the occult forms have normal skin cover. Both forms demand different approaches to management. The clinical importance of occult lesions has grown tremendously in recent years.</p><p>The large number of children suffering from spina bifida and hydrocephalus, though the detection was sporadic by the pediatricians in the past. With the awareness and growth of neurosurgery referral centers, special clinics were established with the ability to address these problems. Gradually, with the availability of magnetic resonance imaging (MRI), several such anomalies were identified, especially of the occult variety. This also helped to visualize a variety of underlying anomalies and their clinical consequences.</p><p>After pediatric neurosurgery became a subspecialty, several neurosurgeons took an interest in this field and contributed to its early detection. Furthermore, there has been a steady decline in these anomalies over the last decade. Folic acid fortification has contributed. Fortification can serve as an effective strategy to prevent neural tube defects (NTDs) in populations where access to folic acid-rich foods or supplements is limited. This review provides an overview of mandatory folic acid (FA) fortification in 71 countries and the research findings on its impact. The programs have shown significant reductions in NTD rates, with reductions of up to 78%. Additionally, blood folate concentrations increased by approximately 1.47 times after fortification. Various health outcomes have also been positively influenced by fortification. As a result, the anomalies that are not compatible with life and the severe anomalies with major defects have decreased, leading to social comfort [<xref ref-type="bibr" rid="scirp.130321-ref3">3</xref>] .</p><p>In this study, we aimed to address the Neurodevelopmental outcomes of Sudanese toddler patients with spinal dysraphism after surgical repair with or without a VP shunt using ASQ-3<sup>TM</sup> Scores.</p></sec><sec id="s2"><title>2. Methodology</title><p>This is a cross-sectional retrospective hospital-based study conducted at the National Center for Neurological Sciences (NCNS) in Khartoum, Sudan which serves as the primary tertiary hospital in Sudan. This facility plays a crucial role in providing healthcare services to approximately 40 million people in Sudan. Notably, it handles over 95% of all myelomeningocele surgeries in the country. Additionally, it is the sole institution offering elective public surgery services in Sudan.</p><p>The study population included all patients who are defined as toddlers (1 - 3 years old) and diagnosed with any of the spinal dysraphism disorders and admitted for surgical repair either for spinal deformity like myelomeningocele repair alone or with VP shunt insertion, which is operated in the NCNS, in the period from 1/1/2017 to 31/12/2019, and there were 84 cases in total. We included the entire patient population who underwent surgery during the specified period, with the sole exception being those who met the exclusion criteria. In essence, our study encompassed all eligible patients, ensuring a total coverage sample size.</p><p>The exclusion criteria for the study encompassed several aspects. Patients were excluded if they declined participation in the study, presented with concurrent congenital conditions such as congenital heart disease or other significant congenital disorders unrelated to the primary research focus, if their contact information was unavailable or died before 1 year. These criteria served as the sole basis for excluding individuals from the study.</p><p>Data is collected by a constructed questionnaire, including ASQ-3<sup>TM</sup> Scores, which assess gross and fine motor skills, communication, problem solving, and personal and social development. Self-regulation, compliance, social communication, adaptive functioning, autonomy, affect, and interaction with people. Ages &amp; Stages Questionnaires<sup>&#174;</sup>, Third Edition (ASQ<sup>&#174;</sup>-3) is a developmental screening tool that pinpoints developmental progress in children between the ages of one month to 5 1/2 years. Its success lies in its parent-centric approach and inherent ease-of-use—a combination that has made it the most widely used developmental screener across the globe. ASQ-3 screens and assesses the developmental performance of children in the areas of communication, gross motor skills, fine motor skills, problem solving, and personal-social skills</p><p>Data were processed and analyzed using the Statistical Package for Social Science (SPSS) computer program. Version 25.0. Study aimed to evaluate neurodevelopment outcome of toddler with spinal dysraphism after surgical repair and to evaluate the impact of post-operative complication in neurodevelopment.</p></sec><sec id="s3"><title>3. Ethical Considerations</title><p>Informed consent was taken from the participant parents and patients privacy and confidentiality taken into consideration.</p></sec><sec id="s4"><title>4. Results</title><p>The gross motor assessment showed the majority of patients (73.8%) need further assessment with professionals, while 7 (8.3%) need to be provided with learning activities and monitored, and only 15 (17.9%) of patients have gross motor development appears to be on schedule (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Fine motor assessment showed that nearly half of the patients (46.5%) On the other hand, 15 of the patients (17.9%) necessitate learning activities and checks, and only about a third (35.7%) of patients have fine motor development, which appears to be on schedule (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Problem-solving assessment showed that 39 of patients (46.4%) need further assessment with professionals, while 9 (10.7%) need to be provided with learning activities and monitored, and 36 (42.9%)’s problem-solving development appears to be on schedule (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patient’s distribution according to their mother attendance to ANC, and receiving folate supplement after conception</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >ANC</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >46.4%</td></tr><tr><td align="center" valign="middle" >Irregular</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >53.6%</td></tr><tr><td align="center" valign="middle" >Received folate supplement</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >35.7%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >64.3%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Patient’s distribution according to type of surgery they underwent</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of surgery</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >percent</th></tr></thead><tr><td align="center" valign="middle" >MMC repair</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >52.3%</td></tr><tr><td align="center" valign="middle" >MMC repair+ PV shunt</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >47.7%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><p>Nevertheless, personal social assessment revealed that the majority (57, 67.9%) of patients need further assessment with professionals, while 18 (21.4%) need to be provided with learning activities and monitored, and only 9 (10.7%) of their personal social development appears to be on schedule (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>Our results provide a symptomatology: 6 of the patients (7.1%) had their parents declare that they have hearing difficulty; additionally, 27 (32.1%) had their parents state that they do not talk like other toddlers their age; moreover, a quarter of patients (22.5%) had their parents report that they do not understand what they say; in addition, 57 (67.9%) of children don’t walk, run, or climb like other toddlers as their parents state; only 3 (3.6%) of parents had concern about their child’s vision; half of patients (50%) had medical problems; but only 12 (14.3%) of parents had concern about child behavior (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>The cross-tabulation results showed that there was a statistically significant association between complications and communication development (P value = 0.017, <xref ref-type="table" rid="table6">Table 6</xref>), problem-solving development (P value = 0.029), Personal social development (P value = 0.028, <xref ref-type="table" rid="table7">Table 7</xref>), and <xref ref-type="table" rid="table8">Table 8</xref>.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Common post-operative complications among patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Complications</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >78.6%</td></tr><tr><td align="center" valign="middle" >Infection</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >VP shunt revision</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7.1%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Communication assessment result among patients using ASQ-3™ Scores</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Communication assessment</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Further assessment with professional may be needed</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >35.7%</td></tr><tr><td align="center" valign="middle" >Providing learning activities and monitor</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >17.9%</td></tr><tr><td align="center" valign="middle" >Development appear to be on schedule</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >46.4%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><disp-formula id="scirp.130321-formula10"><graphic  xlink:href="//html.scirp.org/file/3-2080544x2.png?20231229170948788"  xlink:type="simple"/></disp-formula><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Gross motor assessment result among patients using ASQ-3™ Scores</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Gross motor assessment</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Further assessment with professional may be needed</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >73.8%</td></tr><tr><td align="center" valign="middle" >Providing learning activities and monitor</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >8.3%</td></tr><tr><td align="center" valign="middle" >Development appear to be on schedule</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >17.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><disp-formula id="scirp.130321-formula11"><graphic  xlink:href="//html.scirp.org/file/3-2080544x3.png?20231229170948788"  xlink:type="simple"/></disp-formula><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Fine motor assessment result among patients using ASQ-3™ Scores</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Fine motor assessment</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Further assessment with professional may be needed</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >46.4%</td></tr><tr><td align="center" valign="middle" >Providing learning activities and monitor</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >17.9%</td></tr><tr><td align="center" valign="middle" >Development appear to be on schedule</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >35.7%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><disp-formula id="scirp.130321-formula12"><graphic  xlink:href="//html.scirp.org/file/3-2080544x4.png?20231229170948788"  xlink:type="simple"/></disp-formula></sec><sec id="s5"><title>5. Discussion</title><p>84 patients were included in this study; 51 patients, which constituted 60.7%, were 2 years old, and 33 (39.3%) were 3 years old, <xref ref-type="fig" rid="fig1">Figure 1</xref>. In this study, there were 45 males (53.6%) and 39 females (46.4%), as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Moreover, in this study, 45 of the patients whose mothers attended antenatal care irregularly and 54 (64.3%) of their mothers didn’t receive folate supplements (<xref ref-type="table" rid="table9">Table 9</xref>).</p><table-wrap-group id="7"><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Problem solving assessment result among patients using ASQ-3™ Scores</title></caption><table-wrap id="7_1"><table><tbody><thead><tr><th align="center" valign="middle" >Problem solving</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Further assessment with professional may be needed</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >46.4%</td></tr><tr><td align="center" valign="middle" >Providing learning activities and monitor</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >10.7%</td></tr><tr><td align="center" valign="middle" >Development appear to be on schedule</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >42.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="8"><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Personal social assessment result among patients using ASQ-3™ Scores</title></caption><table-wrap id="8_1"><table><tbody><thead><tr><th align="center" valign="middle" >Personal social</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Further assessment with professional may be needed</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >67.9%</td></tr><tr><td align="center" valign="middle" >Providing learning activities and monitor</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >21.4%</td></tr><tr><td align="center" valign="middle" >Development appear to be on schedule</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >10.7%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100.%</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> Other assessment result among patients using ASQ-3™ Scores</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Hearing well</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >92.9%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7.1%</td></tr><tr><td align="center" valign="middle" >Talk like other toddler in his age</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >67.9%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >32.1%</td></tr><tr><td align="center" valign="middle" >Parents understand what child says</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >75.0%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >25.0%</td></tr><tr><td align="center" valign="middle" >Walk, run or climbs like other toddlers</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >32.1%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >67.9%</td></tr><tr><td align="center" valign="middle" >Family history of hearing impairment</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7.1%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >92.9%</td></tr><tr><td align="center" valign="middle" >Concern about vision</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >96.4%</td></tr><tr><td align="center" valign="middle" >Any medical problem</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >50.0%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >50.0%</td></tr><tr><td align="center" valign="middle" >Concern about behavior</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >85.7%</td></tr><tr><td align="center" valign="middle" >Other concern</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >82.1%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >17.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>Furthermore, 44 patients (52.3%) had MMC repair, while 40 (47.7%) had both repair and PV shunt (<xref ref-type="table" rid="table1">Table 1</xref>0), with a mean age of 73.269.0 days.</p><p>When we came to postoperative complications, infection was the most common reported complication and was seen in 12 (14.3%) of patients, followed by VP shunt revision in 9 (10.7%) of patients (<xref ref-type="table" rid="table1">Table 1</xref>1). In this context, the mean age at VP shunt revision was 51.7 months (range 3 - 7 months).</p><p>Furthermore, communication assessment using ASQ-3<sup>TM</sup> Scores showed that 30 of the patients (35.7%) need further assessment with professionals, while 15 of the patients (17.9%) need to be provided with learning activities and monitored. The rest of the patient’s communication development appears to be on schedule, as shown in <xref ref-type="table" rid="table1">Table 1</xref>2.</p><p>Spinal dysraphism is the most common survivable congenital defect of the central nervous system. We are still lacking the ability to correct the deficits that lead to spinal dysraphism. Our current hope is for novel therapies and optimized</p><table-wrap id="table10" ><label><xref ref-type="table" rid="table1">Table 1</xref>0</label><caption><title> Complications and communication development cross-tabulation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Communication</th><th align="center" valign="middle"  colspan="3"  >Complications</th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >non</td><td align="center" valign="middle" >infection</td><td align="center" valign="middle" >VP shunt revision</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Further assessment with professional may be needed</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >25.0%</td><td align="center" valign="middle" >3.6%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >35.7%</td><td align="center" valign="middle"  rowspan="7"  >0.017</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Providing learning activities and monitor</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >14.3%</td><td align="center" valign="middle" >3.6%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >17.9%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Development appears to be on schedule</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >39</td></tr><tr><td align="center" valign="middle" >39.3%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >46.4%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Total</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >78.6%</td><td align="center" valign="middle" >14.3%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="table11" ><label><xref ref-type="table" rid="table1">Table 1</xref>1</label><caption><title> Complications and Problem-solving development, cross tabulation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Problem solving</th><th align="center" valign="middle"  colspan="3"  >Complication</th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >infection</td><td align="center" valign="middle" >VP shunt revision</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Further assessment with professional may be needed</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >39</td><td align="center" valign="middle"  rowspan="8"  >0.029</td></tr><tr><td align="center" valign="middle" >35.7%</td><td align="center" valign="middle" >3.6%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >46.4%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Providing learning activities and monitor</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >3.6%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >10.7%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Development appear to be on schedule</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >36</td></tr><tr><td align="center" valign="middle" >35.7%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >42.9%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Total</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >78.6%</td><td align="center" valign="middle" >14.3%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="table12" ><label><xref ref-type="table" rid="table1">Table 1</xref>2</label><caption><title> Complications and personal social development, cross tabulation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Personal social</th><th align="center" valign="middle"  colspan="3"  >Complication</th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Infection</td><td align="center" valign="middle" >VP shunt revision</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Further assessment with professional may be needed</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >57</td><td align="center" valign="middle"  rowspan="8"  >0.028</td></tr><tr><td align="center" valign="middle" >46.4%</td><td align="center" valign="middle" >14.3%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >67.9%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Providing learning activities and monitor</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >18</td></tr><tr><td align="center" valign="middle" >21.4%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >21.4%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Development appear to be on schedule</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >10.7%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >0.0%</td><td align="center" valign="middle" >10.7%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Total</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >78.6%</td><td align="center" valign="middle" >14.3%</td><td align="center" valign="middle" >7.1%</td><td align="center" valign="middle" >100.%</td></tr></tbody></table></table-wrap><p>medical and surgical management to provide improved outcomes and quality of life for these patients. In this study, we aimed to assess the neurological outcome of patients with spinal dysraphism after surgical repair and VP if it is done with a shunt. Eighty-four patients were included in this study; out of them, 51 (60.7%) were 2 years old, and 33 (39.3%) were 3 years old.</p><p>Although there is no evidence that the gender of the child influences the risk of developing spinal dysraphism, Overall, it’s more common in females than in males. This study showed a slight male predominance of 1.1:1, in contrast to previous studies, which revealed that the general population had a slight female predominance [<xref ref-type="bibr" rid="scirp.130321-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.130321-ref5">5</xref>] . Moreover, Tubbs RS’s study stated that women are three times more likely than men to have spinal dysraphism [<xref ref-type="bibr" rid="scirp.130321-ref6">6</xref>] .</p><p>The decreased incidence of NTDs is largely due to the prevention of folate deficiency, a risk factor that was implicated as early as the 1960s but not fully appreciated until the late 1980s and early 1990s. Numerous studies have demonstrated a relationship between lower maternal folate levels and a decreased incidence of spinal dysraphism. In addition, randomized clinical trials helped establish the 4 mg/day recommendation for high-risk mothers, defined as women with a previous pregnancy complicated by an NTD [<xref ref-type="bibr" rid="scirp.130321-ref7">7</xref>] .<sup> </sup><sup> </sup></p><p>The methods available for increasing the consumption of folate were alterations in dietary habits, supplementation, and fortification of food. In 1996, the Food and Drug Administration (FDA) authorized folate fortification and, by 1998, mandated it [<xref ref-type="bibr" rid="scirp.130321-ref8">8</xref>] . As of 2021, over 78 countries have mandated folic acid fortification in their flour [<xref ref-type="bibr" rid="scirp.130321-ref9">9</xref>] . Despite the mounting evidence of a decreased incidence of NTDs with folate supplementation, there are still many countries that forgo fortification and continue to have a significant number of births complicated by NTDs. Our data showed that 53.6% of patients mothers did not attend ANC regularly, and 64.3% of patients their mothers didn’t receive folate supplements. As well published in the literature, spinal dysraphism can be prevented by preconception folic acid [<xref ref-type="bibr" rid="scirp.130321-ref10">10</xref>] . The rostral and caudal neural pores close at 6 weeks of gestation. A delayed folic acid supplementation is bound to miss the vital periods of organogenesis and neural tube closure. It is imperative to supplement our cereal grains with folic acid and vitamin B12 to prevent the social and economic burden of birth defects. This strategy has already benefited developed countries [<xref ref-type="bibr" rid="scirp.130321-ref11">11</xref>] .</p><p>On the other hand, Hydrocephalus has until now been considered an almost inevitable sequela of spinal dysraphism in general and especially myelomeningocele. In the neurosurgical literature, reported rates of shunt placement are ~ 80%. It is a neurosurgical aphorism that “the ideal shunt is no shunt.” The shunt placement rate in patients with myelomeningocele has historically been quite high. Studies suggest that patients with myelomeningocele who have had CSF diversion have reduced longevity compared with patients who have not required shunt placement for CSF diversion [<xref ref-type="bibr" rid="scirp.130321-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.130321-ref13">13</xref>] . The mean IQ has been reported to be higher in children with myelomeningocele who have not required shunt placement than in those who have. Clearly, this observation may simply reflect the severity of the disease; the more severe the malformation, the more likely the need for shunt placement, but it is difficult to deny the long-term adverse effects of shunt-related complications in this group, as evidenced by this and other similar studies. This study showed that according to type of surgery, 52.3% of patients underwent MMC repair only, while 47.7% underwent MMC repair and VP shunt, while a cohort study performed by McDowell MM et al. [<xref ref-type="bibr" rid="scirp.130321-ref14">14</xref>] documented a higher percent. 88% of patients with spina bifida underwent CSF shunting; Waqar Aziz R. et al. [<xref ref-type="bibr" rid="scirp.130321-ref15">15</xref>] reported that 76% had CSF shunting. On the other hand, a study in India reported that VP shunts are seen in only 25% of cases [<xref ref-type="bibr" rid="scirp.130321-ref16">16</xref>] , which is considered the lowest frequency.</p><p>Shunt-related complications, including death, have been reported to be greater in patients with myelomeningocele than in those who required shunt placement for the treatment of other conditions. McDowell MM [<xref ref-type="bibr" rid="scirp.130321-ref17">17</xref>] and others have suggested that it is the infective complications of shunt-treated hydrocephalus rather than the hydrocephalus per se that have the greater impact on intelligence in this population. The need for multiple shunt placement procedures also seems to have a negative effect on the long-term outcome [<xref ref-type="bibr" rid="scirp.130321-ref18">18</xref>] . There is also good evidence to suggest that the IQs of patients with myelomeningocele who do not undergo shunt placement are higher than those of their shunt-treated counterparts. In this study, the most Common postoperative complications reported by our patients were infection in 12 (14.3%) of patients, followed by VP shunt revision in 9 (10.7%) of patients, Gursoy K. et al.’s [<xref ref-type="bibr" rid="scirp.130321-ref19">19</xref>] study found that 32.1% of patients had postoperative complications. Demir N. et al. [<xref ref-type="bibr" rid="scirp.130321-ref20">20</xref>] found that following MMC repair, 30 (27.3%) of the patients developed infection, with meningitis/shunt infection in 18 (16.4%) and wound infection in 12 (11%). Our study revealed that Patients who did not experience any post-operative complications showed statistically significant better neurological development (P value = 0.041). This is consistent with Inversetti A. et al.’s [<xref ref-type="bibr" rid="scirp.130321-ref21">21</xref>] study findings that children with spinal dysraphism who did not have complications had scores within the normal range. Also, it has been often mentioned that neurodevelopmental impairment was more likely in shunted children who developed shunt-related complications<sup>.</sup> [<xref ref-type="bibr" rid="scirp.130321-ref22">22</xref>] . However, when corrected for confounding factors such as central nervous system (CNS) infection or intracranial hemorrhage, test scores for shunted and non-shunted children were similar [<xref ref-type="bibr" rid="scirp.130321-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.130321-ref24">24</xref>] . Thus, there is little evidence to suggest that mild to moderate ventricular enlargement is detrimental to neurocognitive outcome; by contrast, shunt-related complications, such as infection or repeated blockage, are more likely to negatively impact long-term outcome.</p><p>As a result of the neurological and medical symptoms of spinal dysraphism, they are at increased risk of neurobehavioral difficulties. In this study, we found that out of 84 patients, 27 (32.1%) did not talk like other toddlers their age; 21 (25%), their parents did not understand what they said; 57 (67.9%) of children didn’t walk, run, or climb like other toddlers; 3 (3.6%) had concern about vision; 42 (50%) had medical problems; and 12 (14.3%) had concern about child behavior. This is consistent with Nagaraj UD et al.’s [<xref ref-type="bibr" rid="scirp.130321-ref25">25</xref>] study, which recorded that even with adapted living arrangements, only half of the patients have an IQ above 80, and many have major learning impairments. Only half of the patients are able to live freely as adults [<xref ref-type="bibr" rid="scirp.130321-ref26">26</xref>] . This may have been interpreted by Jacobs R. et al.’s [<xref ref-type="bibr" rid="scirp.130321-ref27">27</xref>] study findings, which concluded that children with myelomeningocele often experience neurological deficits, including incontinence and motor difficulties, with specific deficits related to the location of the lesion along the spinal cord. Sensory deficits have also been shown to affect both the formation of synaptic connections between neurons in the perinatal period and myelination throughout childhood. These neurologic deficits may interfere with the development of cognitive skills because the physical disabilities that these children experience may restrict their capacity to efficiently interact with the environment. Further, visual and auditory deficits may impact the child’s ability to process information efficiently for learning and acquiring new skills [<xref ref-type="bibr" rid="scirp.130321-ref28">28</xref>] .</p><p>Despite the growing recognition of spinal dysraphism as a potentially life-threatening abnormality in children, up to 15% of patients die by the age of 3 years, and nearly one-third of patients are left with permanent neurological disabilities. We assessed the neurological development of these patients, and unsurprisingly, according to ASQTM Scores 62 (73.8%), gross motor skills needed further assessment with a professional. Fine motor assessment showed that 39 (46.4%) of patients needed further assessment with a professional, Problem-solving assessment showed that 39 (46.4%) of patients need further assessment with professionals, and Personal social assessment showed that 57 (67.9%) of patients need further assessment with professionals. This is in line with Stevenson KL et al.’s findings that among MMC patients at age 2 years, motor function was statistically significantly impaired. A mean of 77.78 is considered to have a high clinical impact on relevant motor disabilities. When dividing motor function at the age of 2 years into fine and gross motor function, only gross motor function was impaired [<xref ref-type="bibr" rid="scirp.130321-ref29">29</xref>] . An explanation for more favorable fine motor function compared to gross motor function is that assessment of motor function at the age of 2 years focuses on gross motor milestones, while fine motor requirements are limited at this age and standardized tests are more thorough at an older age [<xref ref-type="bibr" rid="scirp.130321-ref30">30</xref>] . However, motor function was impaired compared to typically developing children, especially regarding gross motor function, leading to delayed ambulation.</p></sec><sec id="s6"><title>6. Conclusions</title><p>The result showed a slight predominance of male to female ratio of 1.3:1, and the majority of patients’ mothers didn’t receive folate supplements. All patients underwent surgical repair, and over half of patients underwent a VP shunt. The most common postoperative complications were infection, followed by VP shunt revision.</p><p>Patients communication assessment showed that one third of patients needed Further assessment with professionals. The gross motor assessment showed the majority of patients needed further assessment with a professional, Fine motor assessment showed that nearly half of patients needed further assessment with a professional. Problem-solving assessment showed that nearly half of patients needed further assessment with a professional. Personal social assessment showed that the majority of patients needed further assessment by professionals.</p><p>Some patients had apparent problems hearing and talking like other toddlers their age; their parents did not understand what they said; they had other medical problems; they were concerned about child behavior; and the majority of them didn’t walk, run, or climb like other toddlers.</p><p>There was a statistically significant association between neurological development and age at repair, complications, and the type of surgery they underwent.</p></sec><sec id="s7"><title>Recommendations</title><p>Work toward a prenatal diagnosis of spinal dysraphism and planning for a birth in a hospital that provides a high level of nursery care and a neurosurgical unit, thus improving opportunities for early repair.</p><p>One of the main factors that improve neurodevelopment is postsurgical rehab. We recommend including an orthopedist, urologist, and pediatrician who will check for bony and urinary deformities to start early management for those issues.</p><p>Parents and other caregivers are a key part of the team. They can learn how to help manage a child’s condition and how to encourage and support the child emotionally and socially.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Imam, M., Marhoom, F.E., Aldeaf, S., Awad, A., Zidan, A., Ahmed, M.M. and Taha, S. (2024) Evaluation of the Neurodevelopmental Outcome of Toddlers with Spinal Dysraphism after Surgical Repair Using ASQ-3™ Scores. Open Journal of Modern Neurosurgery, 14, 14-29. https://doi.org/10.4236/ojmn.2024.141003</p></sec><sec id="s10"><title>Abbreviations</title><p>CMIIs Chiari Type II Malformations</p><p>CSF Cerebrospinal Fluid</p><p>CT Computed Tomographic</p><p>DQs Developmental Quotients</p><p>ETV Endoscopic Third Ventriculostomy</p><p>ICU Intensive Care Unit</p><p>ICP Intracranial Pressure</p><p>MMC Myelomeningocele</p><p>MRI Magnetic Resonance Imaging</p><p>NCNS National Center for Neurological Sciences</p><p>NPH Normal Pressure Hydrocephalus</p><p>QP Quiet Phase</p><p>RCT Randomized Controlled Trials</p><p>SBM Spina Bifida Meningomyelocele</p><p>SPSS Statistical Package for Social Science</p><p>VA Shunt Ventriculoatrial Shunt</p><p>VP Shunt Ventriculoperitoneal Shunt</p></sec></body><back><ref-list><title>References</title><ref id="scirp.130321-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Harwood-Nash, D.C. and McHugh, K. (1991) Diastematomyelia in 172 Children: The Impact of Modern Neuroradiology. Pediatric Neurosurgery, 16, 247-251. https://doi.org/10.1159/000120535</mixed-citation></ref><ref id="scirp.130321-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Morrow, J.D. and Kelsey, K. (1998) Folic Acid for Prevention of Neural Tube Defects: Pediatric Anticipatory Guidance. Journal of Pediatric Health Care, 12, 55-59. https://doi.org/10.1016/S0891-5245(98)90222-X</mixed-citation></ref><ref id="scirp.130321-ref3"><label>3</label><mixed-citation publication-type="book" xlink:type="simple">Oaks, W. and Gaskill, S. (1992) Symptomatic Chiari Malformations in Childhood. In: Park, T., Ed., Spinal Dysraphism, Blackwell Scientific Publications, Boston, 104-125.</mixed-citation></ref><ref id="scirp.130321-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Crider, K.S., Bailey, L.B. and Berry, R.J. (2011) Folic Acid Food Fortification—Its History, Effect, Concerns, and Future Directions. Nutrients, 3, 370-384. https://doi.org/10.3390/nu3030370</mixed-citation></ref><ref id="scirp.130321-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Schorah, C. (2009) Dick Smithells, Folic Acid, and the Prevention of Neural Tube Defects. Birth Defects Research Part A: Clinical and Molecular Teratology, 85, 254-259. https://doi.org/10.1002/bdra.20544</mixed-citation></ref><ref id="scirp.130321-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Berry, R.J., Li, Z., Erickson, J.D., Li, S., Moore, C.A., Wang, H., Mulinare, J., Zhao, P., Wong, L.Y., Gindler, J., et al. (1999) Prevention of Neural-Tube Defects with Folic Acid in China. The New England Journal of Medicine, 341, 1485-1490. https://doi.org/10.1056/NEJM199911113412001</mixed-citation></ref><ref id="scirp.130321-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Czeizel, A.E., Dudás, I., Paput, L. and Bánhidy, F. (2011) Prevention of Neural-Tube Defects with Periconceptional Folic Acid, Methylfolate, or Multivitamins? Annals of Nutrition and Metabolism, 58, 263-271. https://doi.org/10.1159/000330776</mixed-citation></ref><ref id="scirp.130321-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Smithells, R.W., Sheppard, S., Schorah, C.J., Seller, M.J., Nevin, N.C., Harris, R., Read, A.P. and Fielding, D.W. (1981) Apparent Prevention of Neural Tube Defects by Periconceptional Vitamin Supplementation. Archives of Disease in Childhood, 56, 911-918. https://doi.org/10.1136/adc.56.12.911</mixed-citation></ref><ref id="scirp.130321-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wals, P.D., Tairou, F., Allen, M.I.V., Uh, S.H., Lowry, R.B., Sibbald, B., Evans, J.A., den Hof, M.C.V., Zimmer, P., Crowley, M., et al. (2007) Reduction in Neural-Tube Defects after Folic Acid Fortification in Canada. The New England Journal of Medicine, 357, 135-142. https://doi.org/10.1056/NEJMoa067103</mixed-citation></ref><ref id="scirp.130321-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Williams, L.J., Mai, C.T., Edmonds, L.D., Shaw, G.M., Kirby, R.S., Hobbs, C.A., Sever, L.E., Miller, L.A., Meaney, F.J. and Levitt, M. (2002) Prevalence of Spina Bifida and Anencephaly during the Transition to Mandatory Folic Acid Fortification in the United States. Teratology, 66, 33-39. https://doi.org/10.1002/tera.10060</mixed-citation></ref><ref id="scirp.130321-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Food and Drug Administration (1996) Food Standards: Amendment of Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid. https://www.govinfo.gov/app/details/FR-1996-08-05/96-19803</mixed-citation></ref><ref id="scirp.130321-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Morris, J.K., Addor, M.C., Ballardini, E., Barisic, I., Barrachina-Bonet, L., Braz, P., Cavero-Carbonell, C., Hond, E.D., Garne, E., Gatt, M., et al. (2021) Prevention of Neural Tube Defects in Europe: A Public Health Failure. Frontiers in Pediatrics, 9, Article 647038. https://doi.org/10.3389/fped.2021.647038</mixed-citation></ref><ref id="scirp.130321-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bauer, S.B., Labib, K.B., Dieppa, R.A. and Retik, A.B. (1977) Urodynamic Evaluation of Boy with Myelodysplasia and Incontinence. Urology, 10, 354-362. https://doi.org/10.1016/0090-4295(77)90168-6</mixed-citation></ref><ref id="scirp.130321-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Tubbs, R.S. and Oakes, W.J. (2013) The Chiari Malformations. Springer, New York. https://doi.org/10.1007/978-1-4614-6369-6</mixed-citation></ref><ref id="scirp.130321-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Akalan, N. (2011) Myelomeningocele (Open Spina Bifida)—Surgical Management. Advances and Technical Standards in Neurosurgery, 37, 113-141. https://doi.org/10.1007/978-3-7091-0673-0_5</mixed-citation></ref><ref id="scirp.130321-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Davis, B.E., Daly, C.M., Shurtleff, D.B., Duguay, S., Seidel, K., Loeser, J.D., et al. (2005) Long-Term Survival of Individuals with Myelomeningocele. Pediatric Neurosurgery, 41, 186-191. https://doi.org/10.1159/000086559</mixed-citation></ref><ref id="scirp.130321-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">McDowell, M.M., Blatt, J.E., Deibert, C.P., Zwagerman, N.T., Tempel, Z.J. and Greene, S. (2018) Predictors of Mortality in Children with Myelomeningocele and Symptomatic Chiari Type II Malformation. Journal of Neurosurgery: Pediatrics, 21, 587-596. https://doi.org/10.3171/2018.1.PEDS17496</mixed-citation></ref><ref id="scirp.130321-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Waqar Aziz, R., Muhammad Ali, B. and Hussnain, A. (2015) Frequency of Hydrocephalus in Myelomeningocele Patients in a Tertiary Care Hospital. Journal of Sheikh Zayed Medical College, 6, 882-884.</mixed-citation></ref><ref id="scirp.130321-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Tuli, S., Tuli, J., Drake, J. and Spears, J. (2004) Predictors of Death in Pediatric Patients Requiring Cerebrospinal Fluid Shunts. Journal of Neurosurgery, 100, 442-446. https://doi.org/10.3171/ped.2004.100.5.0442</mixed-citation></ref><ref id="scirp.130321-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ganesh, D., Sagayaraj, B.M., Barua, R.K., Sharma, N. and Ranga, U. (2014) Arnold Chiari Malformation with Spina Bifida: A Lost Opportunity of Folic Acid Supplementation. Journal of Clinical and Diagnostic Research, 8, OD01-OD03. https://doi.org/10.7860/JCDR/2014/11242.5335</mixed-citation></ref><ref id="scirp.130321-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Gursoy, K., Ustun, G.G., Akduman, B., Ozpostaci, M.O., Kankaya, Y. and Kocer, U. (2020) Analysis of Wound Complications of Patients with Meningomyelocele. Turkish Journal of Plastic Surgery, 28, 19-24.</mixed-citation></ref><ref id="scirp.130321-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Demir, N., Peker, E., Gül&amp;#351;en, &amp;#304;., A&amp;#287;engin, K. and Tuncer, O. (2015) Factors Affecting Infection Development after Meningomyelocele Repair in Newborns and the Efficacy of Antibiotic Prophylaxis. Child’s Nervous System, 31, 1355-1359. https://doi.org/10.1007/s00381-015-2701-y</mixed-citation></ref><ref id="scirp.130321-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Inversetti, A., Van der Veeken, L., Thompson, D., Jansen, K., Van Calenbergh, F., Joyeux, L., Bosteels, J. and Deprest, J. (2019) Neurodevelopmental Outcome of Children with Spina Bifida Aperta Repaired Prenatally vs Postnatally: Systematic Review and Meta-Analysis. Ultrasound in Obstetrics &amp; Gynecology, 53, 293-301. https://doi.org/10.1002/uog.20188</mixed-citation></ref><ref id="scirp.130321-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Verhoef, M., Barf, H.A., Post, M.W.M., van Asbeck, F.W.A., Gooskens, R.H.J.M. and Prevo, A.J.H. (2006) Functional Independence among Young Adults with Spina Bifida, in Relation to Hydrocephalus and Level of the Lesion. Developmental Medicine &amp; Child Neurology, 48, 114-119. https://doi.org/10.1017/S0012162206000259</mixed-citation></ref><ref id="scirp.130321-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Tarcan, T., Onol, F.F., Ilker, Y., Alpay, H., Sim&amp;#351;ek, F. and Ozek, M. (2006) The Timing of Primary Neurosurgical Repair Significantly Affects Neurogenic Bladder Prognosis in Children with Myelomeningocele. Journal of Urology, 176, 1161-1165. https://doi.org/10.1016/j.juro.2006.04.042</mixed-citation></ref><ref id="scirp.130321-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Mitchell, L.E., Adzick, S.N., Melchionne, J., Pasquairello, P.S., Sutton, L.N. and Whitehead, A.S. (2004) Spina Bifida. The Lancet, 364, 1885-1895. https://doi.org/10.1016/S0140-6736(04)17445-X</mixed-citation></ref><ref id="scirp.130321-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Nagaraj, U.D., Bierbrauer, K.S., Zhang, B., Peiro, J.L. and Kline-Fath, B.M. (2017) Hindbrain Herniation in Chiari II Malformation on Fetal and Postnatal MRI. American Journal of Neuroradiology, 38, 1031-1036. https://doi.org/10.3174/ajnr.A5116</mixed-citation></ref><ref id="scirp.130321-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Jacobs, R., Northam, E. and Anderson, V. (2001) Cognitive Outcome in Children with Myelomeningocele and Perinatal Hydrocephalus: A Longitudinal Perspective. Journal of Developmental and Physical Disabilities, 13, 389-405. https://doi.org/10.1023/A:1012289513829</mixed-citation></ref><ref id="scirp.130321-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Stevenson, K.L. (2004) Chiari Type II Malformation: Past, Present, and Future. Neurosurgical Focus, 16, 1-7. https://doi.org/10.3171/foc.2004.16.2.6</mixed-citation></ref><ref id="scirp.130321-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Kakebeeke, T.H., Knaier, E., Kochli, S., et al. (2016) Comparison € between the Movement ABC-2 and the Zurich Neuromotor Assessment in Preschool Children. Perceptual and Motor Skills, 123, 687-701. https://doi.org/10.1177/0031512516664991</mixed-citation></ref></ref-list></back></article>